AR and prostate carcinoma: Five out of 124 breast cancer-susceptibility loci overlapped with an oestrogen receptor binding site in breast cancer cells (Supplemental Table 3), and 26 out of 99 prostate cancer-susceptibility loci overlapped with an androgen receptor binding site in prostate cancer cells (Supplemental Table 4).